Abstract
The population of HLA-A2-positive individuals, currently considered serologically homogeneous, can be divided into three subtypes on the basis of antigen recognition by various HLA-A2-specific cytotoxic T lymphocytes (CTLs). When these three types of HLA-A2 antigens were analyzed biochemically, they were found to be distinct. Isoelectric focusing (IEF) of HLA antigens digested with neuraminidase (NANAse) suggested that the difference(s) reside in the polypeptide backbone of the HLA-A2 heavy chain. Biochemical analysis distinguishes three distinct categories of HLA-A2 antigens: (1) a major subtype, designated HLA-A2.I, (2) a minor subtype, designated HLA-A2.II, possessing a more basic isoelectric point (IEP) and (3) a minor HLA-A2 subtype more acidic in its IEP than HLA-A2.I, designated HLA-A2.III. A fourth HLA-A2 subtype could be defined by discordance between cell-mediated lympholysis (CML) typing and biochemical analysis. The latter HLA-A2 antigen was defined as a variant by CTL, but was biochemically indistinguishable from the major subtype HLA-A2.I.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biddison, W. E., Ward, F. E., Shearer, G. M., and Shaw, S.: The self determinants recognized by human virus immune T cells can be distinguished from the serologically defined HLA antigens. J. Immunol. 124: 548–552, 1980a
Biddison, W. E., Krangel, M. S., Strominger, J. L., Ward, F. E., Shearer, G. M., and Shaw, S.: Virus immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum. Immunol. 3: 225–232, 1980b
Biddison, W. E., Kostyu, D. D., Strominger, J. L., and Krangel, M. S.: Delineation of immunologically and biochemically distinct HLA-A2 antigens. J. Immunol. 129: 730–734, 1982
Bradley, B. A., Goulmy, E., Schreuder, I., and van Rood, J. J.: Targets for killer T cells in human lymphocyte differentiation. Its application to cancer. In B. Serrou and C. Rosenfeld (eds.): INSERM SYMPOSIUM no. 8, pp. 231–240. Elsevier/North Holland Biomedical Press, Amsterdam, 1978
Breuning, M. H., Lucas, C. J., Breur, B. S., Engelsma, M. Y., de Lange, G. G., Dekker, A. J., Biddison, W. E., and Iványi, P.: Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self recognition. Hum. Immunol. 5: 259–268, 1983
O'Farell, P. H.: High resolution two dimensional electrophoresis of proteins. J. Biol. Chem. 250: 4007–4021, 1975
Goulmy, E., Termijtelen, A., Bradley, B. A., and van Rood, J. J.: HLA restriction of non-HLA-A,-B,-C and -D cell mediated lympholysis (CML). Tissue Antigens 8: 317–326, 1976
Goulmy, E., van Leeuwen, A., Blokland, E., van Rood, J.J., and Biddison, W. E.: MHC restricted H-Y specific antibodies and cytotoxic T lymphocytes can recognise different self determinants. J. Exp. Med. 155: 1567–1572, 1982
Horai, S., van der Poel, J. J., and Goulmy, E.: Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies. Immunogenetics 16: 135–142, 1982
Kato, S., Iványi, P., Lacko, E., Breur, B., du Bois, R., and Eysvoogel, V. P.: Identification of human CML targets. HLA-B locus (B12) antigen variants defined by CTLs generated between B-locus-identical (B12) responder-stimulator pairs. J. Immunol. 128: 949–955, 1982
Mölders, H. H., Breuning, M. H., lvanyi, P., and Ploegh, H. L.: Biochemical analysis of variant HLA-B27 antigens. Hum. Immunol., in press, 1983
Parham, P., Barnstable, C. J., and Bodmer, W. F.: Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J. Immunol. 123: 342–349, 1979
Pease, L. R., Schulze, D. H., Pfaffenbach, G. M., and Nathenson, S. G.: Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the MHC. Proc. Natl. Acad. Sci. U.S.A., in press, 1983
Pfeffer, P. F. and Thorsby, E.: HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney. Transplantation 33: 52–56, 1982
Ploegh, H. L., Orr, H. T., and Strominger, J. L.: Major histocompatibility antigens: The human (HLA, -A,-B,-C) and marine (H-2K, D) class I molecules. Cell 24: 287–299, 1981
Spits, H., Breuning, M. H., iványi, P., Russo, C., and de Vries, J. E.: In vitro isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens. Immunogenetics 16: 503–512, 1982
Strominger, J. L., Engelhard, V. E., Fuks, A., Guild, B. C., Hyafil, F., Kaufman, J. F., Korman, A. J., Kostyk, T. G., Krangel, M. S., Lancet, D., Lopez de Castro, J. A., Mann, D. L., Orr, H. T., Parham, P. R., Parker, K. C., Ploegh, H. L., Pober, J. S., Robb, R. J., and Shackelford, D. A.: Biochemical analysis of products of the MHC. In M. Dorf (ed.): The Role of the Major Histocompatibility Complex in Immunobiology. pp. 115–172, Garland Publishing Co., New York, 1981
van der Poet, J. J., Pool, J., Goulmy, F., and van Rood, J. J.: Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. If. Definition of three HLA-A2 subtypes by CTLs. Immunogenetics, in press, 1983
Vasilov, R. F., Hahn, A., Mölders, H., van Rood, J. J., Breuning, M. H., and Ploegh, H. L.: Analysis of human class I antigens by two-dimensional gel-electrophoresis. Immunogenetics 17: 333–356, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Poel, J.J., Mölders, H., Thompson, A. et al. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis. Immunogenetics 17, 609–621 (1983). https://doi.org/10.1007/BF00366129
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00366129